Klinika Okulistyczna Jasne Blonia Sp. z o.o.
- Address
- Ul. Rojna 90, 91-134 Lodz, Poland
Klinika Okulistyczna Jasne Blonia - Retinal Disease Research Center
Klinika Okulistyczna Jasne Blonia Sp. z o.o. is a specialized ophthalmology research center with advanced expertise in retinal diseases and innovative treatment approaches. The center demonstrates particular strength in investigating cutting-edge interventions for age-related macular degeneration (AMD), focusing on both exudative and neovascular forms of this sight-threatening condition.
- Advanced surgical techniques for submacular hemorrhage complications in wet AMD, including vitrectomy and subretinal TPA administration
- Novel drug delivery systems for neovascular AMD, including sustained-release technologies such as the Port Delivery System
- Anti-VEGF therapy optimization and comparative effectiveness studies in retinal vascular diseases
The center's research portfolio reflects a commitment to evaluating both innovative surgical interventions and next-generation pharmaceutical delivery methods. By investigating treatments ranging from complex vitreoretinal surgical procedures to extended-duration implantable drug delivery systems, Klinika Okulistyczna Jasne Blonia contributes to advancing therapeutic options for patients with challenging retinal pathologies. Their participation in studies examining refill exchange protocols for sustained drug delivery demonstrates engagement with emerging technologies aimed at reducing treatment burden in chronic retinal disease management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1F. Hoffmann-La Roche AG1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1F. Hoffmann-La Roche AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinika Okulistyczna Jasne Blonia Sp. z o.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Xelafaslatide (ONL1204) in Geographic Atrophy Secondary to Age-related Macular Degeneration: A Phase 2 Randomized Controlled Trial | ONL Therapeutics Inc. | Phase II | Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ranibizumab | 2 | Unknown | 2024-04-09 | 2025-10-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.